RYTM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $21,906,591.60

Rhythm Pharmaceuticals Insider Trading History Chart

Rhythm Pharmaceuticals Share Price & Price History

^$105.36

▲ +1.49 (1.43%)

As of 02/6/2026 04:59 PM ET

Days: 30 | 90 | 365

Rhythm Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/11/2025	Pamela J. Cramer	Insider	Sell	3,350	$111.00	$371,850.00	20,814
10/30/2025	Joseph Shulman	Insider	Sell	9,748	$115.24	$1,123,359.52	8,509
10/28/2025	Joseph Shulman	Insider	Sell	2,815	$115.01	$323,753.15	8,509
10/16/2025	Joseph Shulman	Insider	Sell	14,437	$112.03	$1,617,377.11	8,509
8/21/2025	Joseph Shulman	Insider	Sell	4,188	$100.07	$419,093.16	8,509
8/13/2025	Hunter C. Smith	CFO	Sell	3,477	$96.00	$333,792.00	116,915
8/12/2025	Christopher Paul German	CAO	Sell	1,500	$95.00	$142,500.00	922
8/12/2025	Hunter C. Smith	CFO	Sell	24,611	$96.33	$2,370,777.63	116,915
8/11/2025	Joseph Shulman	Insider	Sell	3,984	$90.08	$358,878.72	8,509
7/29/2025	Pamela J. Cramer	Insider	Sell	1,520	$85.93	$130,613.60	20,814
7/9/2025	Christopher Paul German	CAO	Sell	3,817	$80.75	$308,222.75	922
7/9/2025	Hunter C. Smith	CFO	Sell	42,120	$80.48	$3,389,817.60	116,915
7/9/2025	Joseph Shulman	Insider	Sell	7,969	$77.78	$619,828.82	8,509
7/9/2025	Pamela J. Cramer	Insider	Sell	15,572	$77.13	$1,201,068.36	19,209
7/2/2025	Alastair Garfield	Insider	Sell	1,319	$64.81	$85,484.39	3,126
6/10/2025	Christopher Paul German	CAO	Sell	2,069	$67.19	$139,016.11	1,889
6/6/2025	Pamela J. Cramer	Insider	Sell	7,031	$68.05	$478,459.55	19,209
4/29/2025	Pamela J. Cramer	Insider	Sell	7,031	$65.09	$457,647.79	19,209
4/29/2025	Yann Mazabraud	EVP	Sell	6,745	$65.08	$438,964.60	37,655
4/8/2025	Pamela J. Cramer	Insider	Sell	20,760	$60.14	$1,248,506.40	19,209
4/8/2025	Yann Mazabraud	EVP	Sell	17,750	$60.99	$1,082,572.50	22,620
3/21/2025	Christopher Paul German	CAO	Sell	344	$54.23	$18,655.12	2,889
3/14/2025	Yann Mazabraud	EVP	Sell	75,000	$51.48	$3,861,000.00	40,370
2/19/2025	Christopher Paul German	CAO	Sell	635	$57.22	$36,334.70	2,070
2/19/2025	David P. Meeker	CEO	Sell	9,896	$57.22	$566,249.12	201,281
2/19/2025	Hunter C. Smith	CFO	Sell	2,215	$57.22	$126,742.30	109,929
2/19/2025	Jennifer Kayden Lee	EVP	Sell	2,035	$57.22	$116,442.70	5,858
2/19/2025	Joseph Shulman	Insider	Sell	1,228	$57.22	$70,266.16	8,509
2/12/2025	Jennifer Kayden Lee	EVP	Sell	1,815	$56.39	$102,347.85	3,598
2/11/2025	Hunter C. Smith	CFO	Sell	1,296	$57.51	$74,532.96	106,295
2/11/2025	Joseph Shulman	Insider	Sell	794	$57.51	$45,662.94	6
2/10/2025	Jennifer Kayden Lee	EVP	Sell	4,189	$58.91	$246,773.99	4,409
2/4/2025	David P. Meeker	CEO	Sell	4,278	$59.43	$254,241.54	189,927
2/4/2025	Hunter C. Smith	CFO	Sell	1,678	$59.43	$99,723.54	101,186
2/4/2025	Jennifer Kayden Lee	EVP	Sell	1,447	$59.43	$85,995.21	4,038
2/4/2025	Joseph Shulman	Insider	Sell	1,281	$59.43	$76,129.83	2,657
11/11/2024	Jennifer Kayden Lee	EVP	Sell	66,861	$66.33	$4,434,890.13	972
11/11/2024	Joseph Shulman	insider	Sell	13,281	$66.44	$882,389.64
11/7/2024	Pamela J. Cramer	Insider	Sell	4,688	$65.00	$304,720.00	13,500
9/17/2024	Jennifer L. Good	Director	Sell	31,751	$52.40	$1,663,752.40	3,000
9/10/2024	Lynn A. Tetrault	Director	Sell	17,501	$49.65	$868,924.65	3,000
9/9/2024	Pamela J. Cramer	Insider	Sell	4,099	$50.03	$205,072.97	13,500
8/26/2024	Lynn A. Tetrault	Director	Sell	4,300	$50.01	$215,043.00	3,000
8/26/2024	Pamela J. Cramer	Insider	Sell	3,200	$50.01	$160,032.00	13,500
8/9/2024	Pamela J. Cramer	Insider	Sell	49,006	$45.15	$2,212,620.90	13,500
7/29/2024	Pamela J. Cramer	Insider	Sell	1,395	$49.06	$68,438.70	31,735
7/16/2024	Joseph Shulman	Insider	Sell	10,468	$53.00	$554,804.00	30
7/12/2024	Joseph Shulman	Insider	Sell	5,313	$50.01	$265,703.13	30
5/9/2024	Joseph Shulman	Insider	Sell	3,984	$38.47	$153,264.48	30
4/2/2024	Christopher Paul German	CAO	Sell	368	$41.76	$15,367.68	795
3/21/2024	Joseph Shulman	Insider	Sell	18,235	$40.34	$735,599.90	30
3/19/2024	David P. Meeker	CEO	Sell	45,494	$39.22	$1,784,274.68	174,605
3/19/2024	Hunter C. Smith	CFO	Sell	15,515	$39.22	$608,498.30	97,939
3/19/2024	Yann Mazabraud	EVP	Sell	16,000	$39.22	$627,520.00	24,495
2/14/2024	Joseph Shulman	Insider	Sell	1,089	$50.01	$54,460.89	30
2/12/2024	Hunter C. Smith	CFO	Sell	1,209	$51.38	$62,118.42	80,413
2/12/2024	Joseph Shulman	Insider	Sell	791	$51.38	$40,641.58	3,457
2/12/2024	Yann Mazabraud	EVP	Sell	1,594	$51.38	$81,899.72	7,702
2/9/2024	Joseph Shulman	Insider	Sell	71,774	$50.38	$3,615,974.12	2,686
12/27/2023	Joseph Shulman	Insider	Sell	5,015	$50.01	$250,800.15	1,126
12/5/2023	Hunter C. Smith	CFO	Sell	7,026	$35.06	$246,331.56	61,406
11/24/2023	Hunter C. Smith	CFO	Sell	10,974	$35.02	$384,309.48	61,406
11/8/2023	Jennifer Kayden Lee	EVP	Sell	5,712	$28.90	$165,076.80	1,647
11/3/2023	Jennifer Kayden Lee	EVP	Sell	80	$28.00	$2,240.00	1,647
9/5/2023	Jennifer Kayden Lee	EVP	Sell	6,166	$28.05	$172,956.30	1,647
8/9/2023	Jennifer Kayden Lee	EVP	Sell	1,718	$24.66	$42,365.88	3,294
8/7/2023	Jennifer Kayden Lee	EVP	Sell	11,223	$24.18	$271,372.14	3,294
7/26/2023	Pamela J. Cramer	Insider	Sell	930	$17.64	$16,405.20	8,418
3/29/2023	William T Roberts	CAO	Sell	912	$17.50	$15,960.00	7,872
2/14/2023	Hunter C. Smith	CFO	Sell	702	$26.87	$18,862.74	59,406
2/14/2023	Jennifer Chien	EVP	Sell	635	$26.87	$17,062.45	4,940
2/14/2023	Joseph Shulman	Insider	Sell	554	$26.87	$14,885.98	3,741
2/9/2023	Hunter C. Smith	CFO	Sell	1,398	$27.66	$38,668.68	57,779
2/9/2023	Jennifer Chien	EVP	Sell	1,192	$27.66	$32,970.72	3,556
2/9/2023	Pamela J. Cramer	Insider	Sell	834	$27.66	$23,068.44	6,151
2/9/2023	William T Roberts	CAO	Sell	959	$27.66	$26,525.94	6,294

SEC Filings (Institutional Ownership Changes) for Rhythm Pharmaceuticals (NASDAQ:RYTM)

Institutional Buying and Selling by Quarter

Rhythm Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/6/2026	PNC Financial Services Group Inc.	4,659	$0.50M	0.0%	+10.5%	0.007%
2/6/2026	Handelsbanken Fonder AB	17,521	$1.88M	0.0%	+12.9%	0.026%
2/6/2026	Profund Advisors LLC	21,046	$2.25M	0.1%	+68.9%	0.032%
2/6/2026	ProShare Advisors LLC	12,622	$1.35M	0.0%	+11.7%	0.019%
2/5/2026	DNB Asset Management AS	11,163	$1.20M	0.0%	+101.9%	0.017%
2/4/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	9,200	$0.99M	0.0%	+37.3%	0.014%
2/4/2026	Swiss Life Asset Management Ltd	2,653	$0.28M	0.0%	+7.8%	0.004%
2/3/2026	SBI Securities Co. Ltd.	343	$37K	0.0%	+73.2%	0.001%
2/2/2026	Strs Ohio	12,000	$1.28M	0.0%	-18.9%	0.018%
2/2/2026	Danske Bank A S	1,100	$0.12M	0.0%	N/A	0.002%
1/30/2026	Jennison Associates LLC	918,567	$98.32M	0.1%	+123.2%	1.376%
1/30/2026	State of New Jersey Common Pension Fund D	19,270	$2.06M	0.0%	-7.9%	0.029%
1/30/2026	Keybank National Association OH	3,271	$0.35M	0.0%	N/A	0.005%
1/30/2026	M&T Bank Corp	2,101	$0.23M	0.0%	N/A	0.003%
1/29/2026	Comerica Bank	4,014	$0.43M	0.0%	-98.1%	0.006%
1/29/2026	Pictet Asset Management Holding SA	614,663	$66.19M	0.1%	-10.0%	0.921%
1/29/2026	UBS Group AG	427,236	$45.73M	0.0%	+1.6%	0.640%
1/29/2026	Vanguard Group Inc.	6,210,916	$664.82M	0.0%	+24.3%	9.306%
1/29/2026	China Universal Asset Management Co. Ltd.	10,875	$1.16M	0.1%	-6.6%	0.016%
1/28/2026	Arizona State Retirement System	15,762	$1.69M	0.0%	+0.9%	0.024%
1/28/2026	M&T Bank Corp	85,967	$9.20M	0.0%	N/A	0.129%
1/28/2026	Universal Beteiligungs und Servicegesellschaft mbH	123,537	$13.22M	0.0%	+21.9%	0.185%
1/27/2026	Zurcher Kantonalbank Zurich Cantonalbank	12,435	$1.33M	0.0%	+15.9%	0.019%
1/27/2026	GF Fund Management CO. LTD.	1,310	$0.14M	0.0%	-8.3%	0.002%
1/26/2026	JGP Global Gestao de Recursos Ltda.	2,866	$0.31M	0.2%	-11.9%	0.004%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	3,243	$0.35M	0.0%	+26.3%	0.005%
1/26/2026	CWM LLC	2,767	$0.30M	0.0%	-4.3%	0.004%
1/23/2026	Farther Finance Advisors LLC	642	$69K	0.0%	+82.9%	0.001%
1/23/2026	Yorktown Management & Research Co Inc	3,050	$0.33M	0.3%	N/A	0.005%
1/21/2026	Leo Wealth LLC	6,952	$0.74M	0.1%	-11.6%	0.010%
1/20/2026	Harbor Capital Advisors Inc.	40,896	$4.38M	0.3%	+9.9%	0.061%
1/14/2026	Hennion & Walsh Asset Management Inc.	10,908	$1.17M	0.0%	-75.6%	0.016%
1/14/2026	Wedge Capital Management L L P NC	19,247	$2.06M	0.0%	-13.5%	0.029%
1/14/2026	Exchange Traded Concepts LLC	6,080	$0.65M	0.0%	-4.8%	0.009%
1/12/2026	E. Ohman J or Asset Management AB	6,589	$0.71M	0.0%	-19.8%	0.010%
1/9/2026	SG Americas Securities LLC	11,741	$1.26M	0.0%	-40.0%	0.018%
1/5/2026	GAMMA Investing LLC	361	$39K	0.0%	+48.6%	0.001%
12/2/2025	Swiss Life Asset Management Ltd	2,461	$0.25M	0.0%	N/A	0.004%
11/21/2025	CIBC Bancorp USA Inc.	5,569	$0.56M	0.0%	N/A	0.008%
11/20/2025	Centaurus Financial Inc.	2,389	$0.24M	0.0%	N/A	0.004%
11/19/2025	Captrust Financial Advisors	18,258	$1.84M	0.0%	+4.5%	0.027%
11/18/2025	Cim Investment Management Inc.	2,993	$0.30M	0.1%	N/A	0.004%
11/17/2025	Harvest Investment Services LLC	48,140	$4.86M	1.0%	+211.3%	0.072%
11/17/2025	Castleark Management LLC	42,539	$4.30M	0.1%	N/A	0.064%
11/17/2025	CANADA LIFE ASSURANCE Co	14,395	$1.45M	0.0%	+24.3%	0.022%
11/17/2025	Woodline Partners LP	580,183	$58.59M	0.3%	+12.8%	0.869%
11/17/2025	PDT Partners LLC	86,136	$8.70M	0.5%	-11.8%	0.129%
11/17/2025	Dark Forest Capital Management LP	28,639	$2.89M	0.1%	-17.8%	0.043%
11/17/2025	Voleon Capital Management LP	26,897	$2.72M	0.1%	N/A	0.040%
11/17/2025	Voloridge Investment Management LLC	368,263	$37.19M	0.1%	+8.7%	0.552%
11/17/2025	Polar Capital Holdings Plc	1,244,932	$125.73M	0.6%	-0.5%	1.865%
11/17/2025	Qube Research & Technologies Ltd	238,819	$24.12M	0.0%	-0.6%	0.358%
11/17/2025	RA Capital Management L.P.	5,681,359	$573.76M	7.1%	+2.2%	8.513%
11/17/2025	Northern Trust Corp	510,906	$51.60M	0.0%	+0.1%	0.766%
11/17/2025	Mariner LLC	3,597	$0.36M	0.0%	-16.8%	0.005%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	27,122	$2.74M	0.0%	-16.2%	0.041%
11/17/2025	Integrated Wealth Concepts LLC	2,491	$0.25M	0.0%	N/A	0.004%
11/17/2025	Jain Global LLC	35,110	$3.55M	0.0%	+798.4%	0.053%
11/17/2025	HighVista Strategies LLC	37,482	$3.79M	0.9%	+33.5%	0.056%
11/17/2025	Granahan Investment Management LLC	49,728	$5.02M	0.2%	+20.8%	0.075%
11/17/2025	Fred Alger Management LLC	12,335	$1.25M	0.0%	N/A	0.018%
11/17/2025	First Light Asset Management LLC	180,484	$18.23M	1.7%	N/A	0.270%
11/17/2025	Checkpoint Capital L.P.	763,707	$77.13M	25.8%	-28.0%	1.144%
11/17/2025	Cinctive Capital Management LP	35,156	$3.55M	0.2%	-50.4%	0.053%
11/17/2025	Bank of America Corp DE	233,150	$23.55M	0.0%	+5.0%	0.349%
11/17/2025	Aquatic Capital Management LLC	42,490	$4.29M	0.1%	+974.9%	0.064%
11/17/2025	Algert Global LLC	140,284	$14.17M	0.2%	+133.0%	0.210%
11/17/2025	Alliancebernstein L.P.	979,682	$98.94M	0.0%	+1,493.8%	1.468%
11/17/2025	Ameriprise Financial Inc.	137,967	$13.93M	0.0%	-20.3%	0.207%
11/14/2025	Creative Planning	24,945	$2.52M	0.0%	+44.8%	0.037%
11/14/2025	Lazard Asset Management LLC	30,239	$3.05M	0.0%	-69.6%	0.045%
11/14/2025	SummitTX Capital L.P.	11,869	$1.20M	0.0%	-53.4%	0.018%
11/14/2025	Raymond James Financial Inc.	44,093	$4.45M	0.0%	+318.1%	0.066%
11/14/2025	Bellevue Group AG	9,053	$0.91M	0.0%	-56.7%	0.014%
11/14/2025	Burkehill Global Management LP	20,000	$2.02M	0.1%	N/A	0.030%
11/14/2025	Man Group plc	129,330	$13.06M	0.0%	N/A	0.194%
11/14/2025	Orbimed Advisors LLC	215,152	$21.73M	0.5%	-13.4%	0.322%
11/14/2025	California State Teachers Retirement System	48,934	$4.94M	0.0%	+14.0%	0.073%
11/14/2025	ADAR1 Capital Management LLC	49,571	$5.01M	0.5%	+9.2%	0.074%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	10,726	$1.08M	0.0%	+11.1%	0.016%
11/14/2025	Balyasny Asset Management L.P.	350,008	$35.35M	0.0%	+547.1%	0.524%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	437,472	$44.18M	0.0%	+92.2%	0.656%
11/14/2025	Integral Health Asset Management LLC	220,000	$22.22M	1.5%	+83.3%	0.330%
11/14/2025	Comerica Bank	209,325	$21.14M	0.1%	-30.6%	0.314%
11/14/2025	FORA Capital LLC	3,599	$0.36M	0.1%	N/A	0.005%
11/13/2025	Marshall Wace LLP	171,834	$17.35M	0.0%	-54.3%	0.257%
11/13/2025	Entropy Technologies LP	8,502	$0.86M	0.1%	N/A	0.013%
11/13/2025	Kennedy Capital Management LLC	39,575	$4M	0.1%	-30.8%	0.059%
11/13/2025	Arrowstreet Capital Limited Partnership	6,307	$0.64M	0.0%	N/A	0.009%
11/13/2025	Invesco Ltd.	143,555	$14.50M	0.0%	+108.3%	0.215%
11/13/2025	Sei Investments Co.	31,658	$3.20M	0.0%	-4.5%	0.047%
11/13/2025	UBS Group AG	420,336	$42.45M	0.0%	+66.4%	0.630%
11/13/2025	Connor Clark & Lunn Investment Management Ltd.	121,260	$12.25M	0.0%	+5.3%	0.182%
11/13/2025	BNP Paribas Financial Markets	223,681	$22.59M	0.0%	+118.8%	0.335%
11/13/2025	Franklin Resources Inc.	567,782	$57.34M	0.0%	+4.4%	0.851%
11/13/2025	Capital Research Global Investors	598,247	$60.42M	0.0%	N/A	0.896%
11/13/2025	Legal & General Group Plc	57,376	$5.79M	0.0%	+8.9%	0.086%
11/13/2025	Swiss National Bank	102,300	$10.33M	0.0%	+12.9%	0.153%
11/13/2025	Russell Investments Group Ltd.	157,678	$15.92M	0.0%	+20.4%	0.236%
11/13/2025	Schroder Investment Management Group	18,042	$1.82M	0.0%	+2.4%	0.027%

Data available starting January 2016

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $105.36

$102.05

$109.51

50 Day Range

MA: $106.70

$97.46

$117.62

52 Week Range

Now: $105.36

$45.90

$122.20

Volume

719,877 shs

Average Volume

616,207 shs

Market Capitalization

$7.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

Who are the company insiders with the largest holdings of Rhythm Pharmaceuticals?: Rhythm Pharmaceuticals' top insider shareholders include:
David P Meeker (CEO)
Hunter C Smith (CFO)
Yann Mazabraud (EVP)
Pamela J Cramer (Insider)
Joseph Shulman (Insider)
Jennifer Kayden Lee (EVP)
Alastair Garfield (Insider)
Jennifer L Good (Director)
Lynn A Tetrault (Director)
Christopher Paul German (CAO)
Learn More about top insider investors at Rhythm Pharmaceuticals.
Who are the major institutional investors of Rhythm Pharmaceuticals?: Rhythm Pharmaceuticals' top institutional shareholders include:
Vanguard Group Inc. — 9.31%
Jennison Associates LLC — 1.38%
Pictet Asset Management Holding SA — 0.92%
UBS Group AG — 0.64%
Universal Beteiligungs und Servicegesellschaft mbH — 0.19%
M&T Bank Corp — 0.13%
Learn More about top institutional investors of Rhythm Pharmaceuticals stock.
Which institutional investors are selling Rhythm Pharmaceuticals stock?: Within the last quarter, RYTM stock was sold by these institutional investors:
Comerica Bank
Pictet Asset Management Holding SA
Hennion & Walsh Asset Management Inc.
SG Americas Securities LLC
Wedge Capital Management L L P NC
Strs Ohio
State of New Jersey Common Pension Fund D
E. Ohman J or Asset Management AB
Within the last year, company insiders that have sold Rhythm Pharmaceuticals company stock include:
David P Meeker (CEO)
Hunter C Smith (CFO)
Yann Mazabraud (EVP)
Pamela J Cramer (Insider)
Joseph Shulman (Insider)
Jennifer Kayden Lee (EVP)
Alastair Garfield (Insider)
Jennifer L Good (Director)
Learn More investors selling Rhythm Pharmaceuticals stock.
Which institutional investors are buying Rhythm Pharmaceuticals stock?: In the last quarter, RYTM stock was acquired by institutional investors including:
Vanguard Group Inc.
Jennison Associates LLC
M&T Bank Corp
Universal Beteiligungs und Servicegesellschaft mbH
Profund Advisors LLC
UBS Group AG
DNB Asset Management AS
PSP Research LLC